. 2025 Dec 31;15:17. doi: 10.1186/s13756-025-01685-5

Table 2.

Univariate analysis of potential risk factors associated with prolonged ESBLPE colonisation

Follow up variables		Short colonisation		Long colonisation		P value
Follow up variables		Number	%	Number	%
Residence	Home	45	91.84	44	83.02	0.1821^$
Residence	Long-term care facility	4	8.16	9	16.98	0.1821^$
Intensity of duration of hospitalisation	Median (IQR^#) Range	0% (1.5%) 0-23.9%		1.4% (4.1%) 0-28.9%		0.0036*
Intensity of antibiotic use	Median (IQR^#) Range	7.4% (23.1%) 0-84.9%		7.9% (11.4%) 0-90.1%		0.6778*
Seen General Practitioner	No	3	6.12	1	1.89	0.3485**
Seen General Practitioner	Yes	46	93.88	52	98.11	0.3485**
Urinary catheter placed	No	36	73.47	36	67.92	0.5392^$
Urinary catheter placed	Yes	13	26.53	17	32.08	0.5392^$
Dialysis catheter placed	No	48	97.96	52	98.11	1.0000**
Dialysis catheter placed	Yes	1	2.04	1	1.89	1.0000**
Developed chronic ulcers	No	42	85.71	41	77.36	0.2788^$
Developed chronic ulcers	Yes	7	14.29	12	22.64	0.2788^$
Developed eczema/dermatitis	No	36	73.47	33	62.26	0.2268^$
Developed eczema/dermatitis	Yes	13	26.53	20	37.74	0.2268^$
Developed ESBLPE infection	No	43	87.76	45	84.91	0.6761^$
Developed ESBLPE infection	Yes	6	12.24	8	15.09	0.6761^$
Overseas travel during follow-up	No	32	65.31	37	69.81	0.6270^$
Overseas travel during follow-up	Yes	17	34.69	16	30.19	0.6270^$

ESBLPE: extended-spectrum beta-lactamase-producing Enterobacterales, $ Chi-square test, # interquartile range (Q3-Q1), * Wilcoxon rank sum test, ** Fisher's exact test